Texas
Cancer clinical trials in Texas
894 cancer studies are recruiting participants at sites in 75 cities across Texas as of November 16, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Browse Texas by city
Cities with the most studies recruiting right now.
Houston
624 studies recruiting.
Dallas
243 studies recruiting.
San Antonio
195 studies recruiting.
Every Texas city with a recruiting study
By research area: Lung Cancer (261), Breast Cancer (258), Lymphoma (177), Prostate Cancer (102), Pancreatic Cancer (53), Melanoma (43).
Houston (624), Dallas (243), San Antonio (195), Austin (92), Fort Worth (75), Tyler (41), Irving (39), Sugar Land (34), The Woodlands (28), El Paso (26), Lubbock (21), League City (19), Amarillo (17), Conroe (17), Richardson (16), Abilene (15), Temple (14), Webster (13), Baytown (11), Kingwood (11), Flower Mound (10), Galveston (10), Corpus Christi (9), Cypress (9), Denton (9), McAllen (9), Nassau Bay (9), Palestine (9), Longview (8), Arlington (7), Plano (7), Bedford (6), Denison (6), Odessa (6), Round Rock (6), Waco (6), Allen (5), Grapevine (5), Harlingen (5), Laredo (5), Lewisville (5), McKinney (5), Midland (5), New Braunfels (5), Weslaco (5), Wichita Falls (5), Beaumont (4), Fredericksburg (4), Paris (4), Pearland (4), Edinburg (3), Burleson (2), Fort Sam Houston (2), Forth Worth (2), Humble (2), Spring (2), Weatherford (2), Woodland (2), Anderson (1), Austin, TX 78758 (1), Bellaire (1), Bryan (1), Carrollton (1), Cedar Park (1), Fort Bliss (1), Fort Stockton (1), Frisco (1), Garland (1), Kingswood (1), Kyle (1), Lakeway (1), Nashville (1), Shenandoah (1), Texarkana (1), Woodway (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Breast cancer: recently updated in Texas
Basic details from each study's public record (the 12 most recently updated of 894). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Improving Comprehensive Care of Cancer Patients
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Baylor College of Medicine
- Recruiting in
- Houston
- Registry record
- NCT05323409 · updated
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Boehringer Ingelheim
- Recruiting in
- Houston
- Registry record
- NCT06324357 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Texas on ClinicalTrials.gov.
Lung cancer: recently updated in Texas
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- University of Texas Southwestern Medical Center
- Recruiting in
- Dallas
- Registry record
- NCT02468024 · updated
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- NovoCure GmbH
- Recruiting in
- Dallas · Edinburg · Houston · and 1 more U.S. location
- Registry record
- NCT06216301 · updated
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
- Phase 1/2
- Ages 18 to 75
- All sexes
- Sponsor
- Tyligand Pharmaceuticals (Suzhou) Limited
- Recruiting in
- Houston · San Antonio
- Registry record
- NCT06385925 · updated
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
- Phase 1
- Ages 18 to 99
- All sexes
- Sponsor
- Erasca, Inc.
- Recruiting in
- Houston · Tyler
- Registry record
- NCT06983743 · updated
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- IDEAYA Biosciences
- Recruiting in
- Fort Worth · Houston · Irving
- Registry record
- NCT07277413 · updated
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
- Phase 2/3
- Ages 18 and older
- All sexes
- Sponsor
- Eikon Therapeutics
- Recruiting in
- Fort Worth
- Registry record
- NCT07365319 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Texas on ClinicalTrials.gov.
Lymphoma: recently updated in Texas
Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- M.D. Anderson Cancer Center
- Recruiting in
- Houston
- Registry record
- NCT05011045 · updated
Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- M.D. Anderson Cancer Center
- Recruiting in
- Houston · San Antonio
- Registry record
- NCT05676450 · updated
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Hoffmann-La Roche
- Recruiting in
- Temple · The Woodlands · Tyler
- Registry record
- NCT06806033 · updated
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Nurix Therapeutics, Inc.
- Recruiting in
- Austin · Dallas
- Registry record
- NCT07221500 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Texas on ClinicalTrials.gov.
Ask about studies in Texas
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Oncology Research Hub does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections